tradingkey.logo

Artivion Inc

AORT

31.640USD

+0.720+2.33%
Horário de mercado ETCotações atrasadas em 15 min
1.35BValor de mercado
PerdaP/L TTM

Artivion Inc

31.640

+0.720+2.33%
Mais detalhes de Artivion Inc Empresa
Artivion, Inc. is a medical device company engaged in the manufacturing, processing, and distribution of medical devices and implantable human tissues used in cardiac and vascular surgical procedures for patients with aortic disease, heart valve disease, aortic aneurysms, and dissections. The Company's segments include Medical Devices and Preservation Services. The Medical Devices segment includes sales of aortic stent grafts, surgical sealants, and On-X. The Preservation Services segment includes services for the preservation of cardiac and vascular implantable human tissues. It has four product families: aortic stent grafts, surgical sealants, On-X mechanical heart valves and related surgical products, and implantable cardiac and vascular human tissues. Aortic stent grafts include aortic arch stent grafts, abdominal stent grafts, and synthetic vascular grafts. Surgical sealants include BioGlue Surgical Adhesive products. It also sells or distributes PhotoFix bovine surgical patches.
Informações da empresa
Código da empresaAORT
Nome da EmpresaArtivion Inc
Data de listagemFeb 12, 1993
CEOMr. James Patrick (Pat) Mackin
Número de funcionários1600
Tipo de títulosOrdinary Share
Fim do ano fiscalFeb 12
Endereço1655 Roberts Boulevard N W
CidadeKENNESAW
Bolsa de valoresNYSE Consolidated
PaísUnited States of America
Código postal30144
Telefone17704193355
Sitehttps://artivion.com/
Código da empresaAORT
Data de listagemFeb 12, 1993
CEOMr. James Patrick (Pat) Mackin
Executivos da empresa
Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. John E. Davis
Mr. John E. Davis
Senior Vice President - Global Sales and Marketing
Senior Vice President - Global Sales and Marketing
188.49K
+7.55%
Mr. Daniel J. Bevevino
Mr. Daniel J. Bevevino
Independent Director
Independent Director
150.06K
+4.40%
Mr. Thomas F. Ackerman
Mr. Thomas F. Ackerman
Independent Director
Independent Director
149.90K
+4.41%
Ms. Amy D. Horton, CPA
Ms. Amy D. Horton, CPA
Chief Accounting Officer, Vice President
Chief Accounting Officer, Vice President
142.38K
+6.92%
Mr. Jon W. Salveson
Mr. Jon W. Salveson
Independent Director
Independent Director
129.84K
+5.12%
Mr. Lance A. Berry, CPA
Mr. Lance A. Berry, CPA
Chief Financial Officer, Executive Vice President - Finance
Chief Financial Officer, Executive Vice President - Finance
121.36K
+10.09%
Mr. James W. Bullock
Mr. James W. Bullock
Independent Director
Independent Director
68.65K
+10.15%
Mr. Jeffrey H. (Jeff) Burbank
Mr. Jeffrey H. (Jeff) Burbank
Lead Independent Director
Lead Independent Director
53.80K
+13.32%
Dr. Marshall S. Stanton, M.D.
Dr. Marshall S. Stanton, M.D.
Senior Vice President, Clinical Research and Chief Medical Officer
Senior Vice President, Clinical Research and Chief Medical Officer
48.71K
-45.78%
Mr. Matthew A. (Matt) Getz
Mr. Matthew A. (Matt) Getz
Vice President - Human Resources
Vice President - Human Resources
34.12K
-21.64%
Ver Mais
Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. John E. Davis
Mr. John E. Davis
Senior Vice President - Global Sales and Marketing
Senior Vice President - Global Sales and Marketing
188.49K
+7.55%
Mr. Daniel J. Bevevino
Mr. Daniel J. Bevevino
Independent Director
Independent Director
150.06K
+4.40%
Mr. Thomas F. Ackerman
Mr. Thomas F. Ackerman
Independent Director
Independent Director
149.90K
+4.41%
Ms. Amy D. Horton, CPA
Ms. Amy D. Horton, CPA
Chief Accounting Officer, Vice President
Chief Accounting Officer, Vice President
142.38K
+6.92%
Mr. Jon W. Salveson
Mr. Jon W. Salveson
Independent Director
Independent Director
129.84K
+5.12%
Mr. Lance A. Berry, CPA
Mr. Lance A. Berry, CPA
Chief Financial Officer, Executive Vice President - Finance
Chief Financial Officer, Executive Vice President - Finance
121.36K
+10.09%
Detalhamento da receita
Moeda: USDAtualizado em: dom, 6 de jul
Moeda: USDAtualizado em: dom, 6 de jul
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
Por EmpresaUSD
Nome
Receita
Proporção
Aortic stent grafts
36.60M
36.98%
On X
21.57M
21.80%
Surgical sealants
18.11M
18.29%
Other
2.52M
2.54%
Sem dados
Por Empresa
Por Região
Por EmpresaUSD
Nome
Receita
Proporção
Aortic stent grafts
36.60M
36.98%
On X
21.57M
21.80%
Surgical sealants
18.11M
18.29%
Other
2.52M
2.54%
Distribuição de ações
Atualizado em: sáb, 17 de mai
Atualizado em: sáb, 17 de mai
Investidores
Tipos de investidores
Investidores
Investidores
Proporção
BlackRock Institutional Trust Company, N.A.
13.46%
Macquarie Investment Management
6.80%
Perceptive Advisors LLC
6.54%
Fidelity Management & Research Company LLC
6.51%
The Vanguard Group, Inc.
6.49%
Other
60.19%
Investidores
Investidores
Proporção
BlackRock Institutional Trust Company, N.A.
13.46%
Macquarie Investment Management
6.80%
Perceptive Advisors LLC
6.54%
Fidelity Management & Research Company LLC
6.51%
The Vanguard Group, Inc.
6.49%
Other
60.19%
Tipos de investidores
Investidores
Proporção
Investment Advisor
57.95%
Investment Advisor/Hedge Fund
28.93%
Private Equity
6.54%
Individual Investor
5.25%
Hedge Fund
1.99%
Research Firm
1.20%
Pension Fund
1.06%
Bank and Trust
0.43%
Sovereign Wealth Fund
0.05%
Participação acionária institucional
Atualizado em: ter, 1 de jul
Atualizado em: ter, 1 de jul
Período do relatório
N.º de instituições
Ações detidas
Proporção
Variação
2025Q2
390
44.18M
103.45%
+2.14M
2025Q1
402
44.36M
103.89%
+1.66M
2024Q4
380
41.09M
97.75%
+880.04K
2024Q3
367
38.98M
93.02%
-790.24K
2024Q2
349
38.52M
92.17%
-784.32K
2024Q1
347
38.26M
91.68%
-2.02M
2023Q4
342
37.08M
90.20%
-1.57M
2023Q3
339
37.01M
90.02%
-1.95M
2023Q2
331
37.22M
87.77%
-1.77M
2023Q1
335
37.61M
88.87%
-1.51M
Ver Mais
Atividade dos acionistas
Nome
Ações detidas
Proporção
Variação
Var. %
Data
BlackRock Institutional Trust Company, N.A.
5.75M
13.46%
-106.89K
-1.83%
Mar 31, 2025
Macquarie Investment Management
2.90M
6.8%
+166.78K
+6.09%
Mar 31, 2025
Perceptive Advisors LLC
2.79M
6.54%
--
--
Mar 31, 2025
Fidelity Management & Research Company LLC
2.78M
6.51%
+1.72M
+161.42%
Mar 31, 2025
The Vanguard Group, Inc.
2.77M
6.49%
-22.88K
-0.82%
Mar 31, 2025
Juniper Investment Company, LLC
2.10M
4.91%
--
--
Mar 31, 2025
Morgan Stanley Smith Barney LLC
1.94M
4.54%
-50.93K
-2.56%
Mar 31, 2025
Wellington Management Company, LLP
1.73M
4.05%
+67.33K
+4.06%
Mar 31, 2025
State Street Global Advisors (US)
1.53M
3.59%
-13.74K
-0.89%
Mar 31, 2025
Dimensional Fund Advisors, L.P.
1.31M
3.07%
-160.12K
-10.87%
Mar 31, 2025
Ver Mais
ETFs Relacionados
Atualizado em: sáb, 2 de ago
Atualizado em: sáb, 2 de ago
Nome
Proporção
AAM Sawgrass US Small Cap Quality Growth ETF
2.93%
Unusual Whales Subversive Democratic Trading ETF
2.48%
ROBO Global Healthcare Technology & Innovation ETF
1.7%
SPDR S&P Health Care Equipment ETF
1.64%
Invesco Dorsey Wright Healthcare Momentum ETF
1.53%
Invesco S&P SmallCap Health Care ETF
0.85%
Invesco S&P SmallCap 600 Pure Growth ETF
0.5%
First Trust Small Cap Growth AlphaDEX Fund
0.41%
Invesco S&P SmallCap Momentum ETF
0.39%
Invesco Dorsey Wright SmallCap Momentum ETF
0.37%
Ver Mais
AAM Sawgrass US Small Cap Quality Growth ETF
Proporção2.93%
Unusual Whales Subversive Democratic Trading ETF
Proporção2.48%
ROBO Global Healthcare Technology & Innovation ETF
Proporção1.7%
SPDR S&P Health Care Equipment ETF
Proporção1.64%
Invesco Dorsey Wright Healthcare Momentum ETF
Proporção1.53%
Invesco S&P SmallCap Health Care ETF
Proporção0.85%
Invesco S&P SmallCap 600 Pure Growth ETF
Proporção0.5%
First Trust Small Cap Growth AlphaDEX Fund
Proporção0.41%
Invesco S&P SmallCap Momentum ETF
Proporção0.39%
Invesco Dorsey Wright SmallCap Momentum ETF
Proporção0.37%
Dividendo
Um total de 0.00 USD foi distribuído em dividendos nos últimos 5 anos.
Data
Dividendo
Data de registro
Data de pagamento
Data ex-dividendo
Sem dados
Desdobramento de ações
Data
Tipo
Proporção
Sem dados
Data
Tipo
Proporção
Sem dados
KeyAI